HealthCare Global Enterprises has informed that, pursuant to provisions of Section 110 of the Companies Act, 2013, read with Rule 22 of the Companies (Management and Administration) Rules, 2014, Regulation 44(3) of SEBI Listing Regulations, and further to its intimation to Stock Exchanges on June 08, 2026, the approval of members of the Company was sought by remote e-voting process in respect of the resolutions set out in the Postal Ballot Notice dated June 08, 2026. In this regard, it enclosed the following: (i) Voting Results in compliance with Regulation 44(3) of SEBI Listing Regulations; and (ii) Consolidated Report of the Scrutinizer dated July 09, 2026, issued by, V Sreedharan, Senior Partner, V Sreedharan and Associates, Company Secretaries, on the remote e-voting conducted through the Postal Ballot process, pursuant to the provisions of Section 110 of the Companies Act, 2013 read with Rule 22 of the Companies (Management and Administration) Rules, 2014. Detailed information in this regard in accordance with Regulation 30 read with SEBI Circulars SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and HO/49/14/14(7)2025- CFDPOD2/I/3762/2026 dated January 30, 2026, is annexed as Annexure-A. The above information is also available on the website of the Company and can be accessed at: https://www.hcgoncology.com/.
The above information is a part of company’s filings submitted to BSE.
